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Abstract
Background—Helicobacter pylori cholesterol-α-glucosyltransferase (cgt) is essential for
survival of H. pylori in mice. Enterohepatic H. hepaticus, the cause of colonic and hepatocellular
carcinoma in susceptible mouse strains, contains an ortholog of the H. pylori cgt. However, the
role of cgt in in the pathogenesis of H. hepaticus has not been investigated.
Materials and Methods—Two cgt-deficient isogenic mutants of wild-type H. hepaticus (WT)
3B1 were generated and used to inoculate male A/JCr mice. Cecal and hepatic colonization levels
of the mutants and WT 3B1 as well as select inflammation-associated cytokines were measured by
qPCR at 4 months post-inoculation.
Results—Both mutants were undetectable in the cecum of any inoculated mice (10 per mutant)
but were detected in two livers (one for each mutant); by contrast, 9 and 7 of 10 mice inoculated
with WT 3B1 were qPCR-positive in the ceca and livers, respectively. The mice inoculated with
the mutants developed significantly less severe hepatic inflammation (P < 0.05) and also produced
significantly lower hepatic mRNA levels of proinflammatory cytokines Ifn-γ (P < 0.01) and Tnf-α
(P ≤ 0.02) as well as anti-inflammatory factors Il10 and Foxp3 compared to the WT 3B1-
inoculated mice. Additionally, the WT 3B1-inoculated mice developed significantly higher Th1-
associated IgG2a (P < 0.0001) and Th2-associated IgG1 responses (P < 0.0001) to H. hepaticus
infection than mice dosed with isogenic cgt mutants.
Conclusion—Our data indicate that the cholesterol-α-glucosyltransferase is required for
establishing colonization of the intestine and liver and therefore plays a critical role in the
pathogenesis of H. hepaticus.
Introduction
Cholesterol is an essential component of mammalian cell membranes where it is required to
establish proper membrane permeability and fluidity, but also plays a pivotal role in obesity
and cardiovascular diseases. This molecule can be glycosylated into cholesteryl glucosides
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by glucosyltransferases in plants, most fungi and some animals. Cholesteryl glucosides are
also found in bacteria such as Helicobacter pylori and Acholeplasma axanthum, despite the
fact that prokaryotes do not produce cholesterol. Three major cholesteyl glucosides,
including cholesteryl-α-D-glucopyranoside (αCG) and its two derivatives αCAG
(cholesteryl—6′-O-tetradecanoyl-α-D-glucopyranoside) and αCPG (cholesteryl—6′-O-
phosphatidyl-α-D-glucopyranoside), have been identified and characterized in H. pylori
cells using two-dimensional thin-layer chromatography (1). Subsequently, an H. pylori gene
(HP0421) was identified to encode cholesterol-α-glucosyltransferase (Cgt) which catalyzes
conversion of cholesterol and glucosides into cholesteryl glucosides such as αCG, αCAG
and αCPG (2, 3). In C57BL/6 mice and gerbils, inactivation of cgt in H. pylori increased
host phagocytosis and T cell activation against infection, and the cgt mutants did not sustain
colonization (3, 4). It was reported that gastric mucosa-associated O-glycans inhibited the
growth and motility of H. pylori by disrupting its biosynthesis of αCG. In the presence of
exogenous cholesterol, increased cholesterol glucosylation by H. pylori enhances its
resistance to 8 antibiotics and an antimicrobial peptide LL-37 cathelicidin in vitro (4). These
lines of evidence indicate that cholesteryl glycosides protect H. pylori from the host
immunity.
Helicobacter hepaticus, a prototype of enterohepatic Helicobacter species (EHS), induces
chronic active hepatitis, hepatocellular carcinoma, colon cancer, and inflammatory bowel
disease in susceptible mouse strains and has been widely used as infectious models for
dissecting pathogenic mechanisms of similar human diseases (5, 6). H. hepaticus 16S rDNA
are also detected in human subjects via PCR-based assays (7, 8). Approximately 50% of the
genes predicted from the genome of H. hepaticus are orthologs of H. pylori, including a cgt
ortholog (Hh0676) (9). In addition, the cgt gene is also present in several gastric
helicobacters including H. felis, H. mustelae and H. acinonychis. Among the recently
sequenced genomes of 5 species of EHSs known to infect humans, this gene is identified
only in H. bilis but is absent from the genomes of H. canadensis MIT 98-5491, H. cinaedi
CCUG 1881, H. pullorum MIT 98-5489, H. winghamensis ATCC BAA-430 (at
www.broadinstitute.org/annotation/genome/Helicobacter_group). To explore the role of cgt
in H. hepaticus-induced liver disease in a mouse model of infectious hepatitis, we generated
2 isogenic H. hepaticus cgt mutants and characterized how cgt inactivation influences
intestinal and hepatic colonization, proinflammatory responses and induction of chronic
hepatitis in male A/JCr mice.
Materials and Methods
Bacterial strain, growth media and conditions
Escherichia coli strain Top10 was used as a recipient for cloning, mutagenesis, and plasmid
propagation and was cultured in LB broth or agar supplemented with antibiotics ampicillin
(Amp, 50 μg/ml) and chloramphenicol (Cm, 25 μg/ml) when appropriate. Wild-type H.
hepaticus (WT) 3B1 (ATCC 51449) was cultured on blood agar (Remel, Lexignton, Ky) for
2–3 days under microaerobic conditions (10% H2, 10% CO2, 80% N2) (10). Cm-resistant H.
hepaticus mutants were selected on tryptic soy agar supplemented with 5% sheep blood and
25 μg/ml of Cm (all from Sigma, St. Louis, MO.).
Ge et al. Page 2
Helicobacter. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
DNA preparation and PCR
Chromosomal DNA from murine tissues and cultured bacteria was isolated using the High
Pure PCR Template Preparation Kit (Roche Applied Science, Indianapolis, IN). Plasmid
DNA was prepared using the Aquick minipreparation kit (Qiagen Inc., Valencia, CA). PCR
reactions were conducted in a 50-μl volume containing the following: 10 to 50 ng of DNA
template, 1 X commercial, 100 μg/ml BSA, 500 nM each of forward and reverse primers
and 2.5 units of High Fidelity DNA polymerase (Roche Applied Science). A thermocycling
program of 35 cycles in a Thermocycler Genius (Technie Incorporated, Princeton, NJ)
included denaturation at 94°C for 1 min, followed by annealing at 50–60°C (based on the
respective primers) for 30 sec and extension at 72°C for 1 min.
Construction of isogenic cgtΔcat mutants
Approximately 600-bp fragments upstream and downstream of Hh0676 (cgt) were amplified
from WT 3B1 genomic DNA using primer pairs ZMG169/170 and 171/172, respectively
(Table I). PCR fragments were ligated with pBluescript II SK and subsequently inserted
with a Cm acetyltransferase cassette lacking a transcriptional terminator (catNT) as
illustrated in Figure 1. We previously demonstrated that the catNT has no polar effect on the
downstream gene ureI (11). Authenticity of the ligation and inserted DNA sequences was
confirmed by sequencing (the ABI Genetic Analyzer 3500). Isogenic H. hepaticus cgtΔcat
mutants were generated as described previously (12). CmR isogenic mutants of H. hepaticus
were characterized by PCR and DNA sequencing. Two mutants, cgtΔcatNT1 (cat within the
transcriptional orientation of cgt) and cgtΔcatNT2 (cat opposite to the transcriptional
orientation of cgt), were selected for further characterization in vivo (Figure 1).
In vivo experimental infection
Male A/JCr mice at 4 to 6 weeks of age free of known murine viruses, pathogenic bacteria
including Helicobacter spp. and parasites, were obtained from NCI (Germantown, NY). The
mice were maintained in an Association for Accreditation and Assessment of Laboratory
Animal Care, International-accredited facility in static microisolater cages. Forty male A/JCr
mice were divided into 4 groups of 10 mice dosed with either WT 3B1, cgtΔcatNT1,
cgtΔcatNT2 or sham-dosed with Brucella broth as a control. For oral gavage, bacteria were
cultured on blood agar, suspended in Brucella broth, and adjusted to109 organisms/ml as
estimated by spectrophotometry at OD600nm. Mice received 0.2 ml of fresh inoculum by
gastric gavage every other day for three doses.
Histopathology evaluation
All mice were euthanized at 4 months post-inoculation (MPI). Immediately after euthanasia,
the ileocolic junction and two sagittal sections of each liver lobe were collected for routine
histological processing and sectioning. Haematoxylin and eosin of the liver and intestine
were examined by a veterinary pathologist (SM) blinded to sample identity as previously
described (13). Hepatitis was graded on a 0–4 scale for lobular histologic activity (lobular
hepatitis) and portal activity (portal and/or interface hepatitis).
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qPCR for H. hepaticus and hepatic mRNA levels of selected genes
Tissues for RNA/DNA isolation were frozen in liquid nitrogen immediately after sampling
and stored at −70°C prior to processing. For enumerating H. hepaticus organisms,
chromosomal DNA from the ceca and livers was prepared using a High Pure PCR Template
kit according to the manufacturer’s protocol (Roche Applied Science,). Levels of hepatic
and cecal H. hepaticus were measured by qPCR in the 7500 Fast Sequence Detection
System (Applied Biosystems) as described elsewhere (14). The colonization level of H.
hepaticus was estimated by normalizing to μg of mouse chromosomal DNA measured by
qPCR using the 18S rRNA gene-based primers and probe mixture (Life Technology).
For relative mRNA quantitation of selected genes, total RNA from livers of A/JCr mice was
prepared using Trizol reagent according to manufacturer’s recommendations (Invitrogen,
Carlsbad, CA). Five μg of total RNA from each sample was converted into cDNA using the
High Capacity cDNA Archive kit (Applied Biosystems). Levels of Ifn-γ, Tnf-α, Il10 and
Foxp3 mRNA were measured by qPCR using commercial primers and probes (TaqMan
Gene Expression Assays) in the 7500 FAST Sequence Detection System. Transcript levels
were normalized to the endogenous control glyceraldehyde-3-phosphate dehydrogenase
mRNA (Gapdh), and expressed as fold change compared with sham-dosed control mice
using the Comparative CT method (Applied Biosystems User Bulletin no. 2).
IgG1 and IgG2a responses to H. hepaticus antigens
Sera was collected from all mice at necropsy (4 MPI) and evaluated by ELISA for Th1-
associated IgG2a and Th2-associated IgG1 antibody responses to outer membrane antigens
(OMPs) of WT H. hepaticus 3B1. Preparation of OMPs and ELISA were conducted as
previously described (15).
Phylogenetic analysis of known and putative bacterial Cgts
To identify and compare orthologs of bacterial Cgts, the putative H. hepaticus Cgt (deduced
based on Hh0676) was used as a query sequence for searching homologs currently available
in public databases using the Blastp at the website of the National Center of Biotechnology
Information. Amino acid sequences of genes with ≥30% identity over 300 amino acids
compared to the H. hepaticus Cgt were selected for phylogenetic analyses. Where putative
Cgt orthologs are present in multiple species within the genus such as Lactobacillus,
Bifidobacterium or Clostridium, only 2 better characterized species were chosen. A
phylogenetic tree was generated using Lasergene software (DNASTAR, Inc., Madison, WI).
Statistical analyses
All statistical analyses were performed using the GraphPad Prism 5 software package.
Histopathological scores were compared using a Mann–Whitney non-parametric t-test. Data
on the colonization levels of H. hepaticus and cytokine mRNA in the tissues were analyzed
using two-tailed Student’s t-test. Serology results were compared using regression, ANOVA
and the Student’s t-test. Values of p<0.05 were considered significant.
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Results
Cgt is required for intestinal colonization and is important for persistent hepatic
colonization by H. hepaticus
It was previously reported that inactivation of the H. pylori cgt resulted in failure of isogenic
mutants to colonize stomachs of C57BL/6 mice at 12 hours post inoculation and gerbils by
one month PI (3, 4). To characterize a role for cgt in the colonization and pathogenesis of H.
hepaticus, colonization efficiencies of 2 cgt isogenic mutants cgtΔcatNT1 and cgtΔcatNT2
of WT 3B1 in parallel with WT 3B1 were examined by qPCR in male A/JCr mice (10 per
group), a mouse model of infectious hepatitis and hepatocellular carcinoma At 4 MPI, 9 of
10 WT 3B1-dosed mice were qPCR-positive for H. hepaticus in the ceca and 7 out of 10
livers (Figure 2). In contrast, all mice dosed with either mutant were negative for H.
hepaticus in the ceca and qPCR-positive only in one of 10 livers for each cgt mutant.
A/JCr mice infected with cgt-deficient H. hepaticus mutants did not develop hepatic
pathology
Infection with H. hepaticus leads to hepatic inflammation by 4 MPI in male A/JCr mice (11,
13, 16, 17). Consistent with these previous findings, 5 of 10 male mice infected with WT
3B1 developed subacute-to-chronic hepatitis characterized by multifocal lobular hepatitis
with coagulative necrosis, and mild to moderate lymphocyte-predominant portal and
interface hepatitis (Fig. 3A, 6–9 for hepatitis index scores). The observation that 5 WT 3B1-
infected mice did not develop overt hepatitis is in agreement with our previous observation
that a subset of A/JCr mice appears resistant to H. hepaticus-induced hepatic disease (13).
This resistance was supported by relatively lower levels of H. hepaticus colonization in the
liver (~100-fold) compared to mice with hepatitis (Fig. 2). In contrast, no overt hepatic
pathology was evident in male A/JCr mice inoculated with the cgt-deficient H. hepaticus
mutants, including one mouse from each group that was PCR positive for H. hepaticus in the
liver (Figure 2). Hepatitis indices in WT 3B1-infected mice were significantly higher than in
the cgt mutants-infected mice or the sham controls (P < 0.05, Fig. 3B); there were no
significant differences in hepatitis indices between mice inoculated with the isogenic
mutants or the sham-dosed controls. These data indicate that infection with the cgt-deficient
H. hepaticus mutants did not lead to the development of chronic active hepatitis as observed
in the WT 3B1-dosed male A/JCr mice. This was consistent with the inability of the mutants
to colonize the intestine and liver. Histopathological evaluation of the intestines of all mice
did not reveal significant lesions.
mRNA levels of hepatic Tnf-α, Ifn-γ, Il10 and Foxp3 were significantly higher in WT H.
hepaticus-infected mice than mice dosed with cgt mutants
Previous studies showed that WT 3B1 infection significantly elevated expression of
proinflammatory cytokines in splenocyte culture and in livers of male A/JCr mice (11, 15,
17). To ascertain how infection with the cgt mutants influence hepatic proinflammatory
responses compared to WT 3B1 infection, mRNA levels of proinflammatory Ifn-γ and Tnf-
α, and anti-inflammatory Il-10 as well as Foxp3, a marker for natural regulatory T cells,
were measured in cDNA prepared from hepatic RNA (Figure 4). In the liver of mice
infected with the cgt mutants, significantly lower mRNA levels of Ifn-γ (P < 0.01), Tnf-α (P
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< 0.05), Il10 (P <0.05) and Foxp3 (P < 0.05) were observed compared to mice infected with
WT 3B1. Consistent with a lack of overt hepatic pathology, mRNA levels of these hepatic
cytokines in the two mice, which were positive for H. hepatics cgt mutants, were similar to
those in the cgt mutant-negative mice from the same groups. There were no significant
differences in mRNA levels of these targets between the cgt mutant-infected mice and the
sham-dosed controls (P > 0.2), except Ifn-γ mRNA was lower in the cgtΔcat1-dosed mice
compared to the sham controls (P<0.05) (Fig. 4).
Serum levels of IgG1 and IgG2a were significantly higher in WT H. hepaticus 3B1-infected
mice
Th1-associated IgG2a and Th2-associated IgG1 responses to WT 3B1- and cgt mutants-
infection were compared by ELISA. WT 3B1-dosed male A/JCr mice developed
significantly higher levels of both IgG2a (P < 0.0001) and IgG1 (P < 0.0001) responses to
infection than the cgt mutants-dosed mice, consistent with the lack of colonization by cgt
mutants (Figure 2).
Cgt-like proteins are present in diverse bacterial species
Twenty-one Cgt-like bacterial proteins were retrieved from the databases and
phylogenetically analyzed. These gene products belong to the cd03178 family whose
members are UDP-glucose-diacylglycerol glucosyltransferase-like proteins and are most
closely related to the GT1 super family of glycosyltransferases. Six gastric Helicobacter
species and 2 EHS contain the Cgt-like enzymes (Figure 6). Interestingly, the sequence of
the Cgt-like protein in gastric H. mustelae is more similar to those from EHS H. hepaticus
and H. bilis than those from other gastric helicobacters (Figure 6). Additionally, the
sequences of the Cgt-like proteins in Clostridium thermocellum and Treponema
brennaborenese are distantly related to those from Clostridium methhylpentosum and
Treponema azotonutricium, respectively, despite belonging to the same genus. It is also
interesting to note that the genomes of multiple species in the genera Lactobacillus and
Bifidobacterium, including probiotic L. acidophilus and B. bifidum, contain genes coding for
Cgt-like proteins.
Discussion
Members of the genus Helicobacter are grouped into two groups based on their preferential
colonization niches: gastric species and enterohepatic species (18). The human pathogen H.
pylori, the prototype of gastric helicobacters, can extract cholesterol from the epithelial
membrane of host cells and convert it into cholesteryl-α-glucosides via Cgt. The loss of Cgt
function leads to clearance of H. pylori by the host within 12 hours post innoculation in
C57BL/6 mice or one month in gerbils (3, 4). Intriguingly, orthologs of cgt are found in the
genomes of 6 gastric Helicobacter species but only present in two of 6 EHS species
analyzed, H. hepaticus and H. bilis. Our data demonstrate that H. hepaticus Cgt plays a
pivotal role in establishing cecal colonization. In addition, only one of 10 mice infected with
each of the two cgt mutants was PCR-positive for H. hepaticus in the liver, suggesting that
this enzyme is also important for hepatic colonization of this bacterium. Reduced
colonization efficiency of the cgt mutants in the liver may result from inefficient
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translocation of the bacteria from the intestine to the liver due to their clearance in the
intestine (19). Alternatively, the cgt mutants may be cleared from the liver after their
translocation. Interestingly, the cgt mutant-colonized livers, like other H. hepaticus-free
cohorts in the same groups, did not develop hepatic inflammation nor up- regulate
transcription of proinflammatory cytokines, Ifn-γ and Tnf-α or anti-inflammatory mediators
Il10 and Foxp3; these two mice also induced less IgG1 and IgG2a responses, when
compared to WT 3B1-dosed mice. These results were not apparently caused by a polar
effect or spontaneous mutations elsewhere in the genome for the following reasons. Firstly,
we previously showed that the allelic replacement of ureA/B with catNT lacking its
transcription terminator did not down-regulate the transcription of its downstream gene ureI
in the ure operon of H. hepaticus (11). Secondly, two cgt-deficient mutants containing a
catNT with opposite orientations conferred similar clinical manifestations. Thirdly, a -35
(TTTATA), a 21-nucleotide spacer and a -10 (TAAAAT) elements conserved among
bacterial promoters precede HH0677 which locates immediately downstream of the H.
hepaticus cgt (Hh0676), indicating that transcription of Hh0677 is likely controlled under its
own promoter (Figure 1A).
Pathogenic bacteria, which are likely tohave coevolved with their hosts, have developed
multiple strategies for colonization success. Bacteria utilize various protein secretion
systems, dynamic cell surface structures as well as virulence factors to evade host immunity,
survive in complex ecosystems, and maintain pathogenicity. Cholesterol is present in the
membranes of eukaryotic organisms and has various cellular functions including
maintenance of the membrane structure, modulation of membrane fluidity and involvement
in cell signaling (20, 21). However, the mechanisms underlying the importance of the
biosynthesis of cholesteryl-α-glucosides for the gastrointestinal and hepatic colonization of
helicobacters require further studies. Accumulated evidence suggests that Cgt-mediated
cholesterol α-glucosylation confers several advantages for H. pylori to survive in the host.
First, this bacterium utilizes this process to escape phagocystosis and eventual ingestion by
antigen presenting cells including macrophages, a first line of defense in innate immunity
(3). Second, this process helps H. pylori evade T cell-mediated immune responses of the
host via reduction of T cell proliferation (3, 22). Third, α-glucosylation of cholesterol
apparently increases resistance to bactericidal effects by the host mucus-associated O-
glycans and cathelicidin LL-37 as well as select antibiotics (1, 4, 23). These advantages may
be attributed to reduction of the availability of cholesterol for the host antibacterial response.
We hypothesize that H. hepaticus, which preferentially colonizes the large intestine and the
liver, also encounter cholesterol-mediated antibacterial effects similar to that described for
H. pylori colonizing the stomach. It is known that approximately 80% of total body
cholesterol is endogenously produced primarily in the liver and intestine (24).
Epidemiological data indicate there is an inverse association between H. pylori infection and
prevalence of allergic asthma (25, 26). In vivo studies demonstrated that infection with H.
pylori protected neonatal mice from experimentally induced asthma via expansion of
regulatory T cells driven by dendritic cell-derived Il-18 or neutrophil activation protein-
mediated downregulation of Th2 responses (27–29). Interestingly, a recent report indicated
that treatment with a glycolipid P157, a chemically synthesized version of the H. pylori
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αCAG described previously (1, 3), protected suckling BALB/c mice against ovalbumin
(allergen)-induced airway hyperreactivity (30). This protection resulted from activation of
natural killer T cells mediated by CD1d (related to class I MHC molecules) (30). Given that
production of the H. pylori αCAG requires Cgt, the presence of cgt orthologs in EHS such
as H. hepaticus and H. bilis as well as other enteric bacteria implies that bacterial glycolipids
catalyzed by Cgt may have broad immune regulatory effects in human health and disease.
Blastp search and phylogenetic analyses suggest that diverse bacterial species have the
potential to synthesize Cgt-like proteins. Distribution of this gene in members of the same
genus is not ubiquitous; for example, only some members of Helicobacter or Clostridium
are positive for homologs of Cgt. Whether these predicted proteins have enzymatic activity
to conduct α-glucosylation of cholesterol remains unknown. However, significant sequence
homology between H. pylori and other Cgt-like proteins suggests that at least some of these
proteins could be Cgts.
Taken together, the results from this study and previous reports demonstrate that cholesterol
α–glucosylation plays a pivotal role in colonization of both gastric and enterohepatic
helicobacters in the gastrointestinal and hepatic tissues of mice and gerbils. Given the role of
H. pylori cholesteryl α-glucosides in phagocytosis, immune evasion and protection against
allergic asthma, our results further highlight the physiological and pathogenic potential of
these bacterial cholestoryl glucosydes warrant further investigations into expression and
biological functions of cholestoryl glucosydes in medically important cgt-positive bacteria,
including additional Helicobacter, Clostridium, Lactobacillus and Bifidobacterum species.
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Figure 1.
Construction of cgt-deficient H. hepaticus mutants. A, Genomic locus (indicated by
numbers) of H. hepaticus cgt (HH0676) and its flanking genes. B, Genotypes of WT 3B1
and 2 cgt mutants are schematically depicted. Locations of PCR primers used for generating
and characterizing the mutants are denoted.
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Figure 2.
Deficiency in cgt impaired the ability of H. hepaticus to persistently colonize the intestine
and liver of male A/JCr mice (n=10 per group). Numbers represent the copies of the H.
hepaticus genome per μg mouse DNA in the individual samples.
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Figure 3.
Histology of the livers of male A/JCr mice dosed by WT 3B1 or cgt-deficient mutants
cgtΔcat1 and cgtΔcat2 at 4 months post inoculation. A. Representative histopathology. (a)
Normal liver, sham-inoculated mouse. (b) and (c) Minimal hepatic inflammation present in
the livers of mice dosed with the isogenic mutants. (d) Subacute hepatitis with
hepatocellular coagulative necrosis induced by WT 3B1. B. Hepatitis index for male A/JCr
mice. The cgt mutant-infected mice developed significantly less severe hepatitis compared
to those infected with WT 3B1.
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Figure 4.
Mice dosed with the cgt mutants expressed lower mRNA levels of hepatic proinflammatory
Th1 cytokine Tnf-α and Ifn-γ as well as antiinflammatory mediators Il10 and Foxp3
compared to the WT 3B1-dosed mice. In each sample, the target gene mRNA was
normalized to the transcript levels of Gapdh. Numbers on the y axis represent mean fold
change of the individual mRNA levels in reference to the control group (0 defined as no
change with its standard deviations denoted). P values versus WT 3B1-infected samples: * <
0.05, ** <0.01, *** <0.001.
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Figure 5.
Male A/JCr mouse Th1-associated IgG2a and Th2-associated IgG1 responses to WT 3B1
outer membrane antigens measured by ELISA. WT 3B1–dosed mice produced significantly
higher levels of sera IgG2a and IgG1 compared to the cgt mutant-dosed mice, which is
consistent with the failure of these cgt mutants to colonize or persist in the host.
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Figure 6.
Phylogenetic analyses of bacterial Cgts. Majority of Cgt protein sequences were deduced
from genome sequences. The phylogenetic tree was constructed using the DNASTAR
software package.
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Table I
Primer sequences used for generating cgt isogenic mutants of H. hepaticus
Primers Sequence (5′ to 3′), Strand
ZMG16 Sense
ZMG170 Antisense
ZMG171 Sense
ZMG172 Antisense
Numbers (+, downstream; −, upstream) denote starting nucleotide positions of primers in correspondence to the start codon of the H. hepaticus cgt
(Hh0676).
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